title: [Myocardial revascularization: the new European guidelines].
abstract: The updated 2014 ESC guidelines on myocardial revascularization did indeed impact on current practice. Some of the most important changes are summarized in this review. Importantly, the recommendation for dual antiplatelet therapy after stenting in stable patients was reduced to 6 months. Also, a more liberal use of PCI in left main stem disease was proposed by the ESC guideline committee.
authors.affiliation: Medizinische Klinik für Kardiologie, Charité - Universitätsmedizin Berlin (Campus Benjamin Franklin).
authors.forename: Georg
authors.initials: G
authors.lastname: Fröhlich
authors.affiliation: Medizinische Klinik für Kardiologie, Charité - Universitätsmedizin Berlin (Campus Benjamin Franklin).
authors.forename: Ulf
authors.initials: U
authors.lastname: Landmesser
mesh_terms: D020341:Absorbable Implants / Q000639:trends; D054058:Acute Coronary Syndrome / Q000628:therapy; D060050:Angina, Stable / Q000628:therapy; D002318:Cardiovascular Diseases / Q000628:therapy*; D054855:Drug-Eluting Stents; D005060:Europe; D006801:Humans; D017202:Myocardial Ischemia / Q000628:therapy; D009204:Myocardial Revascularization / Q000379:methods / Q000592:standards / Q000639:trends; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage* / Q000145:classification; D017410:Practice Guidelines as Topic
chemical_list: D010975:Platelet Aggregation Inhibitors